Novel First-in-Class Treatments
Cleave Biosciences has a pipeline of novel, first-in-class therapeutics for difficult to treat cancers as well as a deep understanding of the biology of the UPS and autophagy pathways. We are interested to establish, development and commercialization partners for our programs. If interested, please contact us at info@cleavebio.com
